Medtronic's Diabetes Spinoff MiniMed Seeks $742M IPO
Diabetes-focused MiniMed Group on Tuesday launched plans to go public by raising an estimated $742 million in an initial public offering, a move that is part of a previously announced plan...To view the full article, register now.
Already a subscriber? Click here to view full article